Milroy disease and the VEGFR-3 mutation phenotype
Open Access
- 1 February 2005
- journal article
- review article
- Published by BMJ in Journal of Medical Genetics
- Vol. 42 (2), 98-102
- https://doi.org/10.1136/jmg.2004.024802
Abstract
Primary congenital lymphoedema (Milroy disease) is a rare autosomal dominant condition for which a major causative gene defect has recently been determined. Mutations in the vascular endothelial growth factor receptor 3 (VEGFR-3) gene have now been described in 13 families world-wide. This is a review of the condition based on the clinical findings in 71 subjects from 10 families. All 71 individuals have a mutation in VEGFR-3. Ninety per cent of the 71 individuals carrying a VEGFR-3 mutation showed signs of oedema, which was confined in all cases to the lower limbs. In all but two cases onset of swelling was from birth. Other symptoms and signs included cellulitis (20%), large calibre leg veins (23%), papillomatosis (10%), and upslanting toenails (10%). In males, hydrocoele was the next most common finding after oedema (37%). Thorough clinical examination of these patients indicates that there are few clinical signs in addition to lower limb oedema. Rigorous phenotyping of patients produces a high yield of VEGFR-3 mutations.Keywords
This publication has 17 references indexed in Scilit:
- Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veinsNature Immunology, 2003
- Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedemaJournal of Medical Genetics, 2003
- Mutations in the Transcription Factor Gene SOX18 Underlie Recessive and Dominant Forms of Hypotrichosis-Lymphedema-TelangiectasiaAmerican Journal of Human Genetics, 2003
- Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side EffectsThe Journal of Experimental Medicine, 2002
- Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24Journal of Medical Genetics, 2002
- Analysis of lymphoedema-distichiasis families forFOXC2 mutations reveals small insertions and deletions throughout the geneHuman Genetics, 2001
- Mutations in FOXC2 (MFH-1), a Forkhead Family Transcription Factor, Are Responsible for the Hereditary Lymphedema-Distichiasis SyndromeAmerican Journal of Human Genetics, 2000
- Congenital Hereditary Lymphedema Caused by a Mutation That Inactivates VEGFR3 Tyrosine KinaseAmerican Journal of Human Genetics, 2000
- Mapping of Primary Congenital Lymphedema to the 5q35.3 RegionAmerican Journal of Human Genetics, 1999
- Managing lymphedemaClinics in Dermatology, 1995